JAMES BEASLEY: Open Payments
NPI 1285019380 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,665 in 81 payments from 18 companies in 2025. Trend: 2023 $435 · 2024 $2,043 · 2025 $1,665
Food & beverage: $1,665
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $322 |
| AstraZeneca Pharmaceuticals LP | 14 | $264 |
| ABBVIE INC. | 10 | $217 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $152 |
| SHIELD THERAPEUTICS INC | 9 | $140 |
| Abbott Laboratories | 6 | $128 |
| GlaxoSmithKline, LLC. | 4 | $85 |
| Lilly USA, LLC | 4 | $62 |
| Seqirus USA Inc | 2 | $55 |
| Exact Sciences Corporation | 3 | $46 |
Products named: AIRSUPRA, Kerendia, Ozempic, UBRELVY, ACCRUFER, Wegovy, TRELEGY ELLIPTA, BREZTRI.
Industry payments across TN — which companies pay providers there.
